STAAR Surgical Company (STAA)
USD 24.26
(-4.64%)
USD 24.26
(-4.64%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 28.09 Million USD | -35.85% |
| 2022 | 43.8 Million USD | 31.38% |
| 2021 | 33.33 Million USD | 392.52% |
| 2020 | 6.76 Million USD | -42.89% |
| 2019 | 11.85 Million USD | 79.71% |
| 2018 | 6.59 Million USD | 281.63% |
| 2017 | -3.63 Million USD | 71.31% |
| 2016 | -12.65 Million USD | -137.12% |
| 2015 | -5.33 Million USD | 33.51% |
| 2014 | -8.02 Million USD | -1246.71% |
| 2013 | 700 Thousand USD | 157.38% |
| 2012 | -1.22 Million USD | -143.84% |
| 2011 | 2.78 Million USD | 206.96% |
| 2010 | -2.6 Million USD | 30.22% |
| 2009 | -3.72 Million USD | 81.71% |
| 2008 | -20.38 Million USD | -44.39% |
| 2007 | -14.11 Million USD | -3.8% |
| 2006 | -13.6 Million USD | -25.8% |
| 2005 | -10.81 Million USD | -6.44% |
| 2004 | -10.15 Million USD | -55.68% |
| 2003 | -6.52 Million USD | 8.27% |
| 2002 | -7.11 Million USD | 60.01% |
| 2001 | -17.78 Million USD | 11.87% |
| 2000 | -20.18 Million USD | -604.55% |
| 1999 | 4 Million USD | -39.39% |
| 1998 | 6.6 Million USD | -29.03% |
| 1997 | 9.3 Million USD | -7.92% |
| 1996 | 10.1 Million USD | 42.25% |
| 1995 | 7.1 Million USD | 29.09% |
| 1994 | 5.5 Million USD | 189.47% |
| 1993 | 1.9 Million USD | 141.3% |
| 1992 | -4.6 Million USD | 58.93% |
| 1991 | -11.2 Million USD | -173.17% |
| 1990 | -4.1 Million USD | -13.89% |
| 1989 | -3.6 Million USD | -33.33% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -2.28 Million USD | -121.92% |
| 2024 Q2 | 11.89 Million USD | 621.61% |
| 2024 Q3 | 5.68 Million USD | -52.24% |
| 2023 Q3 | 6.29 Million USD | -26.78% |
| 2023 FY | 28.09 Million USD | -35.85% |
| 2023 Q4 | 10.4 Million USD | 65.29% |
| 2023 Q1 | 2.8 Million USD | 190.46% |
| 2023 Q2 | 8.59 Million USD | 207.04% |
| 2022 Q3 | 13.7 Million USD | -19.48% |
| 2022 FY | 43.8 Million USD | 31.38% |
| 2022 Q1 | 12.11 Million USD | 64.07% |
| 2022 Q2 | 17.02 Million USD | 40.51% |
| 2022 Q4 | 964 Thousand USD | -92.97% |
| 2021 Q1 | 7.47 Million USD | 83.22% |
| 2021 Q2 | 10.64 Million USD | 42.56% |
| 2021 FY | 33.33 Million USD | 392.52% |
| 2021 Q3 | 7.83 Million USD | -26.41% |
| 2021 Q4 | 7.38 Million USD | -5.79% |
| 2020 FY | 6.76 Million USD | -42.89% |
| 2020 Q2 | -1.05 Million USD | 7.05% |
| 2020 Q3 | 4.88 Million USD | 562.75% |
| 2020 Q4 | 4.07 Million USD | -16.49% |
| 2020 Q1 | -1.13 Million USD | -148.46% |
| 2019 Q2 | 4.61 Million USD | 194.63% |
| 2019 Q1 | 1.56 Million USD | 31.84% |
| 2019 FY | 11.85 Million USD | 79.71% |
| 2019 Q4 | 2.34 Million USD | -29.75% |
| 2019 Q3 | 3.33 Million USD | -27.69% |
| 2018 Q4 | 1.18 Million USD | -25.02% |
| 2018 Q2 | 3.02 Million USD | 278.72% |
| 2018 Q1 | 799 Thousand USD | 163.41% |
| 2018 FY | 6.59 Million USD | 281.63% |
| 2018 Q3 | 1.58 Million USD | -47.69% |
| 2017 FY | -3.63 Million USD | 71.31% |
| 2017 Q4 | -1.26 Million USD | -220.81% |
| 2017 Q3 | 1.04 Million USD | 179.02% |
| 2017 Q2 | -1.32 Million USD | 36.99% |
| 2017 Q1 | -2.09 Million USD | -266.8% |
| 2016 Q4 | 1.25 Million USD | 173.24% |
| 2016 Q1 | -10.05 Million USD | -15607.81% |
| 2016 Q2 | -2.14 Million USD | 78.69% |
| 2016 FY | -12.65 Million USD | -137.12% |
| 2016 Q3 | -1.71 Million USD | 19.93% |
| 2015 Q1 | -1.51 Million USD | 59.65% |
| 2015 Q3 | -2.02 Million USD | -16.01% |
| 2015 FY | -5.33 Million USD | 33.51% |
| 2015 Q4 | -64 Thousand USD | 96.83% |
| 2015 Q2 | -1.74 Million USD | -15.43% |
| 2014 Q3 | -1.55 Million USD | -11.73% |
| 2014 Q1 | -1.34 Million USD | -7.27% |
| 2014 Q2 | -1.39 Million USD | -3.58% |
| 2014 FY | -8.02 Million USD | -1246.71% |
| 2014 Q4 | -3.74 Million USD | -140.95% |
| 2013 Q4 | -1.25 Million USD | -823.12% |
| 2013 FY | 700 Thousand USD | 157.38% |
| 2013 Q1 | 1.08 Million USD | 187.21% |
| 2013 Q2 | 694 Thousand USD | -35.98% |
| 2013 Q3 | 173 Thousand USD | -75.07% |
| 2012 Q2 | -164 Thousand USD | -158.99% |
| 2012 Q1 | 278 Thousand USD | -58.38% |
| 2012 Q4 | -1.24 Million USD | -1265.93% |
| 2012 Q3 | -91 Thousand USD | 44.51% |
| 2012 FY | -1.22 Million USD | -143.84% |
| 2011 FY | 2.78 Million USD | 206.96% |
| 2011 Q3 | 737 Thousand USD | -37.01% |
| 2011 Q2 | 1.17 Million USD | 462.5% |
| 2011 Q4 | 668 Thousand USD | -9.36% |
| 2011 Q1 | 208 Thousand USD | 130.23% |
| 2010 Q2 | -799 Thousand USD | -1151.32% |
| 2010 FY | -2.6 Million USD | 30.22% |
| 2010 Q4 | -688 Thousand USD | 42.28% |
| 2010 Q3 | -1.19 Million USD | -49.19% |
| 2010 Q1 | 76 Thousand USD | 109.96% |
| 2009 Q1 | -1.13 Million USD | 86.26% |
| 2009 FY | -3.72 Million USD | 81.71% |
| 2009 Q4 | -763 Thousand USD | 34.73% |
| 2009 Q3 | -1.16 Million USD | -76.05% |
| 2009 Q2 | -664 Thousand USD | 41.45% |
| 2008 FY | -20.38 Million USD | -44.39% |
| 2008 Q1 | -8.72 Million USD | -140.25% |
| 2008 Q2 | -1.98 Million USD | 77.19% |
| 2008 Q3 | -1.42 Million USD | 28.31% |
| 2008 Q4 | -8.25 Million USD | -478.61% |
| 2007 FY | -14.11 Million USD | -3.8% |
| 2007 Q1 | -3.2 Million USD | 31.26% |
| 2007 Q2 | -3.67 Million USD | -14.75% |
| 2007 Q3 | -3.61 Million USD | 1.53% |
| 2007 Q4 | -3.63 Million USD | -0.39% |
| 2006 Q4 | -4.65 Million USD | -72.79% |
| 2006 FY | -13.6 Million USD | -25.8% |
| 2006 Q3 | -2.69 Million USD | 11.47% |
| 2006 Q1 | -3.21 Million USD | 8.78% |
| 2006 Q2 | -3.04 Million USD | 5.2% |
| 2005 Q4 | -3.51 Million USD | -5.74% |
| 2005 FY | -10.81 Million USD | -6.44% |
| 2005 Q2 | -1.93 Million USD | 5.16% |
| 2005 Q3 | -3.32 Million USD | -72.44% |
| 2005 Q1 | -2.03 Million USD | 46.71% |
| 2004 Q2 | -3.27 Million USD | -236.59% |
| 2004 Q4 | -3.81 Million USD | -82.73% |
| 2004 Q1 | -973 Thousand USD | 59.88% |
| 2004 FY | -10.15 Million USD | -55.68% |
| 2004 Q3 | -2.09 Million USD | 36.18% |
| 2003 Q2 | -957 Thousand USD | -48.37% |
| 2003 FY | -6.52 Million USD | 8.27% |
| 2003 Q1 | -645 Thousand USD | 3.87% |
| 2003 Q3 | -2.49 Million USD | -161.02% |
| 2003 Q4 | -2.42 Million USD | 2.92% |
| 2002 Q3 | -1.69 Million USD | 42.94% |
| 2002 Q1 | -1.76 Million USD | 76.62% |
| 2002 Q2 | -2.97 Million USD | -68.33% |
| 2002 FY | -7.11 Million USD | 60.01% |
| 2002 Q4 | -671 Thousand USD | 60.48% |
| 2001 Q3 | -2.86 Million USD | 59.17% |
| 2001 Q1 | -346 Thousand USD | 97.63% |
| 2001 Q2 | -7.01 Million USD | -1927.17% |
| 2001 FY | -17.78 Million USD | 11.87% |
| 2001 Q4 | -7.56 Million USD | -164.0% |
| 2000 Q3 | 1.04 Million USD | 114.99% |
| 2000 Q4 | -14.58 Million USD | -1493.1% |
| 2000 FY | -20.18 Million USD | -604.55% |
| 2000 Q2 | -6.98 Million USD | -2158.45% |
| 2000 Q1 | 339.33 Thousand USD | 213.11% |
| 1999 Q3 | 1.3 Million USD | -7.14% |
| 1999 FY | 4 Million USD | -39.39% |
| 1999 Q4 | -300 Thousand USD | -123.08% |
| 1999 Q2 | 1.4 Million USD | 0.0% |
| 1999 Q1 | 1.4 Million USD | 566.67% |
| 1998 Q1 | 2.7 Million USD | 800.0% |
| 1998 FY | 6.6 Million USD | -29.03% |
| 1998 Q4 | -300 Thousand USD | -123.08% |
| 1998 Q3 | 1.3 Million USD | -53.57% |
| 1998 Q2 | 2.8 Million USD | 3.7% |
| 1997 Q3 | 3.3 Million USD | 13.79% |
| 1997 Q4 | 300 Thousand USD | -90.91% |
| 1997 Q2 | 2.9 Million USD | 20.83% |
| 1997 FY | 9.3 Million USD | -7.92% |
| 1997 Q1 | 2.4 Million USD | -14.29% |
| 1996 FY | 10.1 Million USD | 42.25% |
| 1996 Q4 | 2.8 Million USD | 0.0% |
| 1996 Q3 | 2.8 Million USD | 27.27% |
| 1996 Q2 | 2.2 Million USD | 10.0% |
| 1996 Q1 | 2 Million USD | 11.11% |
| 1995 Q2 | 1.6 Million USD | 6.67% |
| 1995 FY | 7.1 Million USD | 29.09% |
| 1995 Q4 | 1.8 Million USD | -18.18% |
| 1995 Q3 | 2.2 Million USD | 37.5% |
| 1995 Q1 | 1.5 Million USD | -21.05% |
| 1994 FY | 5.5 Million USD | 189.47% |
| 1994 Q1 | 900 Thousand USD | 12.5% |
| 1994 Q2 | 1.2 Million USD | 33.33% |
| 1994 Q3 | 1.5 Million USD | 25.0% |
| 1994 Q4 | 1.9 Million USD | 26.67% |
| 1993 Q3 | 500 Thousand USD | 25.0% |
| 1993 Q4 | 800 Thousand USD | 60.0% |
| 1993 Q2 | 400 Thousand USD | -90.7% |
| 1993 Q1 | 4.3 Million USD | 138.05% |
| 1993 FY | 1.9 Million USD | 141.3% |
| 1992 Q1 | 2 Million USD | 114.6% |
| 1992 Q4 | -11.3 Million USD | -570.83% |
| 1992 FY | -4.6 Million USD | 58.93% |
| 1992 Q3 | 2.4 Million USD | 4.35% |
| 1992 Q2 | 2.3 Million USD | 15.0% |
| 1991 Q4 | -13.7 Million USD | -1812.5% |
| 1991 Q1 | -1.4 Million USD | 92.27% |
| 1991 Q2 | 900 Thousand USD | 164.29% |
| 1991 FY | -11.2 Million USD | -173.17% |
| 1991 Q3 | 800 Thousand USD | -11.11% |
| 1990 FY | -4.1 Million USD | -13.89% |
| 1990 Q1 | 6.2 Million USD | 189.86% |
| 1990 Q2 | 6.3 Million USD | 1.61% |
| 1990 Q4 | -18.1 Million USD | -1306.67% |
| 1990 Q3 | 1.5 Million USD | -76.19% |
| 1989 Q4 | -6.9 Million USD | -727.27% |
| 1989 Q1 | 1.1 Million USD | 114.1% |
| 1989 Q2 | 1.1 Million USD | 0.0% |
| 1989 Q3 | 1.1 Million USD | 0.0% |
| 1989 FY | -3.6 Million USD | -33.33% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 148.722% |
| AngioDynamics, Inc. | -97.71 Million USD | 128.753% |
| AtriCure, Inc. | -26.68 Million USD | 205.299% |
| Avinger, Inc. | -16.63 Million USD | 268.903% |
| Azenta, Inc. | -73.12 Million USD | 138.423% |
| BioLife Solutions, Inc. | -70.82 Million USD | 139.671% |
| The Cooper Companies, Inc. | 533.1 Million USD | 94.73% |
| Daxor Corporation | -177.07 Thousand USD | 15967.288% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 285.925% |
| Femasys Inc. | -14.5 Million USD | 293.66% |
| GlucoTrack, Inc. | -7.1 Million USD | 495.51% |
| Harvard Bioscience, Inc. | 1.89 Million USD | -1383.474% |
| Hologic, Inc. | 882.6 Million USD | 96.817% |
| ICU Medical, Inc. | 22.82 Million USD | -23.097% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 98.41% |
| KORU Medical Systems, Inc. | -10.26 Million USD | 373.584% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 24.23% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 507.171% |
| Innovative Eyewear, Inc. | -6.9 Million USD | 507.171% |
| Masimo Corporation | 136.5 Million USD | 79.416% |
| Microbot Medical Inc. | -9.85 Million USD | 385.104% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | -91.462% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 77.331% |
| Nephros, Inc. | -1.59 Million USD | 1863.779% |
| NovoCure Limited | -232.87 Million USD | 112.066% |
| NEXGEL, Inc. | -3.47 Million USD | 908.082% |
| NEXGEL, Inc. | -3.47 Million USD | 908.082% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 127.331% |
| OraSure Technologies, Inc. | 54.07 Million USD | 48.045% |
| Pro-Dex, Inc. | 7.17 Million USD | -291.705% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 164.481% |
| Predictive Oncology Inc. | -13.92 Million USD | 301.827% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | 1131.335% |
| QuidelOrtho Corporation | 139.1 Million USD | 79.801% |
| Repligen Corporation | 54.57 Million USD | 48.518% |
| Sanara MedTech Inc. | -4.21 Million USD | 766.571% |
| Sharps Technology, Inc. | -10.12 Million USD | 377.456% |
| Utah Medical Products, Inc. | 16.77 Million USD | -67.473% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 133.055% |
| Jin Medical International Ltd. | 2.86 Million USD | -879.924% |